Think Bioscience Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 29

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $55M

  • Investors
  • 19

Think Bioscience General Information

Description

Developer of reimagining synthetic biology systems designed to guide the design and assembly of better medicines. The company's technology encodes a sophisticated molecular objective into a microbial host to identify, build, and evolve small molecules, enabling medical researchers to use microbes in drug discovery.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1745 38th Street
  • Suite 150
  • Boulder, CO 80301
  • United States
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • 1745 38th Street
  • Suite 150
  • Boulder, CO 80301
  • United States

Think Bioscience Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Think Bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series A) 20-Jan-2026 $55M Completed Generating Revenue
7. Seed Round 06-May-2024 Completed Generating Revenue
6. Grant 25-Nov-2022 Completed Generating Revenue
5. Seed Round 18-Aug-2022 Completed Generating Revenue
4. Accelerator/Incubator 15-Oct-2021 Completed Generating Revenue
3. Grant 17-Dec-2020 Completed Generating Revenue
2. Accelerator/Incubator 30-Nov-2020 $250K $250K Completed Generating Revenue
1. Grant 23-Nov-2020 $125K Completed Generating Revenue
To view Think Bioscience’s complete valuation and funding history, request access »

Think Bioscience Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-4
Series A-3
Series A-1
Series A-2
Seed-2A
Seed-2
Seed-1D
Seed-1C
Seed-1B 1,466,606 $0.000010 $0.44 $0.44 1x $0.44 0.64%
Seed-1A 940,203 $0.000010 $0.27 $0.27 1x $0.27 0.41%
To view Think Bioscience’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Think Bioscience Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of reimagining synthetic biology systems designed to guide the design and assembly of better medicines. The co
Drug Discovery
Boulder, CO
29 As of 2026

London, United Kingdom

Paris, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Think Bioscience Competitors (41)

One of Think Bioscience’s 41 competitors is Generative Tensorial Networks, a Formerly VC-backed company based in London, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Generative Tensorial Networks Formerly VC-backed London, United Kingdom
Eligo Bioscience Venture Capital-Backed Paris, France
Second Genome Formerly VC-backed Brisbane, CA
Mustang Bio Formerly VC-backed Waltham, MA
NGM Biopharmaceuticals Private Equity-Backed South San Francisco, CA
You’re viewing 5 of 41 competitors. Get the full list »

Think Bioscience Patents

Think Bioscience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3237159-A1 Methods and systems for high-throughput biochemical screens Pending 03-Nov-2021
EP-4426882-A1 Methods and systems for high-throughput biochemical screens Pending 03-Nov-2021
US-20250034551-A1 Methods and systems for high-throughput biochemical screens Pending 03-Nov-2021
WO-2023081783-A1 Methods and systems for high-throughput biochemical screens Inactive 03-Nov-2021 C12N15/1055

Think Bioscience Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Think Bioscience Investors (19)

Investor Name Investor Type Holding Investor Since Participating Rounds
CE-Ventures Corporate Venture Capital Minority
Janus Henderson Investors Asset Manager Minority
MBX Capital Venture Capital Minority
Regeneron Ventures Corporate Venture Capital Minority
T.A. Springer Corporation Minority
You’re viewing 5 of 19 investors. Get the full list »

Think Bioscience FAQs

  • When was Think Bioscience founded?

    Think Bioscience was founded in 2019.

  • Where is Think Bioscience headquartered?

    Think Bioscience is headquartered in Boulder, CO.

  • What is the size of Think Bioscience?

    Think Bioscience has 29 total employees.

  • What industry is Think Bioscience in?

    Think Bioscience’s primary industry is Drug Discovery.

  • Is Think Bioscience a private or public company?

    Think Bioscience is a Private company.

  • What is the current valuation of Think Bioscience?

    The current valuation of Think Bioscience is .

  • What is Think Bioscience’s current revenue?

    The current revenue for Think Bioscience is .

  • How much funding has Think Bioscience raised over time?

    Think Bioscience has raised $78.2M.

  • Who are Think Bioscience’s investors?

    CE-Ventures, Janus Henderson Investors, MBX Capital, Regeneron Ventures, and T.A. Springer are 5 of 19 investors who have invested in Think Bioscience.

  • Who are Think Bioscience’s competitors?

    Generative Tensorial Networks, Eligo Bioscience, Second Genome, Mustang Bio, and NGM Biopharmaceuticals are some of the 41 competitors of Think Bioscience.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process